Deepali Pandey, MBBS

Deepali Pandey practices at Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health.

Deepali Pandey's NPI, 1003268392, was assigned on July 11, 2016. Deepali Pandey holds Kentucky license 53868.

Deepali Pandey's primary practice is Northern Light Eastern Maine Medical Center, at 489 State Street, Bangor, ME 04401 in Penobscot County. The practice phone is (207) 973-7000.

Deepali Pandey's primary practice is Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health. Deepali Pandey is also affiliated with Northern Light Maine Coast Hospital. The medical group on file is Northern Light Eastern Maine Medical Center. Dmand AI also links Deepali Pandey to 3 more hospitals and 1 breast imaging center, each named with a free account. Deepali Pandey's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Deepali Pandey practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Deepali Pandey's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Deepali Pandey is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Deepali Pandey's licenses on file in 3 states: Kentucky, Massachusetts and New York.

CMS data shows 300 Medicare services from Deepali Pandey across 2 procedure codes in 2024, all of them office visits, for 180 Medicare patients. Medicare paid $30,939 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 180 Medicare patients who saw Deepali Pandey in 2024. The largest group is 65 to 74, with 83 patients. 70% of them have high blood pressure, and 67% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Deepali Pandey's median patient age at 68, with 67% women.

In 2024, Deepali Pandey wrote 378 Medicare Part D claims for 123 patients. 85% of them were for generic drugs. CMS names the drug for 233 of them, across 10 drugs with 11 or more claims each, at $608,172 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Deepali Pandey for performance year 2024, reported as part of a group. Deepali Pandey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Deepali Pandey as offering telehealth.

CMS Open Payments shows 19 general payments to Deepali Pandey from 8 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $115.